Wang J D, Kong W M, Jiang H
Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China.
Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):94-98. doi: 10.3760/cma.j.issn.0253-3766.2020.02.002.
Globally, cervical cancer continues to be one of the most common cancers among females. Although screening for cervical cancer has been gradually carried out, the incidence and mortality of cervical cancer in China are still at a high level. So the prevention and treatment of cervical cancer in China still has lots of work to do. The International Federation of Obstetrics and Gynecology (FIGO) gynecological oncology committee revised the staging of cervical cancer in 2018. The new staging changed in terms of stage ⅠB and stage Ⅲ compared with previous FIGO staging. FIGO also provided prevention and treatment strategies and the treatment regimens of each stage, which had an important impact on the prevention and treatment of cervical cancer as well as an important enlightenment for China.
在全球范围内,宫颈癌仍然是女性中最常见的癌症之一。尽管宫颈癌筛查已逐步开展,但中国宫颈癌的发病率和死亡率仍处于较高水平。因此,中国宫颈癌的防治工作仍有大量工作要做。国际妇产科联盟(FIGO)妇科肿瘤委员会于2018年修订了宫颈癌分期。与之前的FIGO分期相比,新分期在ⅠB期和Ⅲ期方面有所变化。FIGO还提供了各阶段的防治策略和治疗方案,这对宫颈癌的防治具有重要影响,也为中国提供了重要启示。